Imedeen

Imedeen is a nutricosmetic. It was developed in the 1980s by the Swedish biochemist Ake Dahlgren. Dahlgren observed that certain marine extracts taken orally could help protect and restore the structure and function of the skin. This effect has been shown in clinical study.[1][2][3]

The Imedeen trademark is owned by Pfizer

References

  1. ↑ Heule F (1992). "An Oral Approach to the Treatment of Photodamaged Skin: a Pilot Study". Journal of International Medical Research. 20 (3): 273–278. PMID 1397672.
  2. ↑ Heule F (1994). "The improvement of the consequences of cutaneous aging". Journal of the European Academy of Dermatology and Venereology. 3 (2): 224. doi:10.1111/j.1468-3083.1994.tb00104.x.
  3. ↑ Kieffer ME and Efsen J (1998). "Imedeen in the treatment of photoaged skin: an efficacy and safety trial over 12 months". Journal of the European Academy of Dermatology and Venereology. 11 (2): 129–136. doi:10.1016/s0926-9959(98)00061-0. PMID 9784038.

External links

This article is issued from Wikipedia - version of the 5/31/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.